# Anavex Life Sciences Corp.: Form 8-K, filed Jun 21, 2024

- Company: [Anavex Life Sciences Corp.](/companies/avxl.md) (CIK 1314052)
- Form: 8-K
- Filed: 2024-06-21
- Accepted by EDGAR: Jun 21, 2024, 16:30 ET
- Period: 2024-06-18
- Accession: 0001731122-24-001003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1314052/000173112224001003/e5761_8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1314052/000173112224001003/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1314052/000173112224001003/e5761_8-k.htm

Filed Jun 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001731122-24-001003. Last ingested by Listed: Nov 6, 2026, 20:17 ET. No prices; not investment advice.